Smoking may increase the usage of antidepressant: evidence from genomic perspective analysis

Yucai Qu,Zhiqiang Du,Yuan Shen,Qin Zhou,Zhenhe Zhou,Ying Jiang,Haohao Zhu
DOI: https://doi.org/10.1007/s00406-024-01802-2
2024-05-08
European Archives of Psychiatry and Clinical Neuroscience
Abstract:This study uses the two-sample Mendelian randomization (TSMR) method to explore the causal relationships between smoking initiation (SMKI), never smoking (NSMK), past tobacco smoking (PTSMK), and the usage of antidepressants (ATD). Single-nucleotide polymorphisms (SNPs) with genome-wide significance ( P < 5E−08) related to SMKI, NSMK, and PTSMK were selected from the genome-wide association study (GWAS) database as instrumental variables (IVs). The main method, inverse variance weighted (IVW), was utilized to investigate the causal relationship. The results demonstrated a positive causal relationship between SMKI and ATD use, where SMKI leads to an increase in ATD use. Conversely, NSMK and PTSMK showed a negative causal relationship with ATD use, meaning that NSMK and PTSMK lead to a reduction in ATD use. Additionally, sensitivity analysis showed that the results of this study were robust and reliable. Using the TSMR method and from a genetic perspective, this study found that SMKI leads to an increase in ATD use, while NSMK and PTSMK reduce ATD use.
psychiatry,clinical neurology
What problem does this paper attempt to address?